• HOME (current)
  • MEETINGS ARCHIVE
    2019 RANZCO 2018 RANZCO 2017 RANZCO 2016 RANZCO 2015 RANZCO 2014 RANZCO 2013 RANZCO 2012 RANZCO
  • ADVANCED SEARCH
  • 2016 RANZCO HANDBOOK
Home > 2019 RANZCO > Strabismus

Session : Strabismus


SESSION INFORMATION

Date:      -

Time:      -

Meeting: 2019 RANZCO

ABSTRACT NUMBER : A234
Outcomes of medial rectus elevation and creation of a V‐pattern for the management of large angle divergence insufficiency type esotropia
ABSTRACT NUMBER : A235
Inferior oblique belly transposition for V pattern strabismus
ABSTRACT NUMBER : A236
Clinical observation: The changes of dominant eyes before and after operation in patients with intermittent exotropia
ABSTRACT NUMBER : A237
Clinical and genetic analysis for the Chinese patients with congenital cranial dysinnervation disorders (CCDDs)
ABSTRACT NUMBER : A238
Clinical profile, management and treatment outcomes of Acquired Brown Syndrome: Case series from a tertiary eye care centre in India
ABSTRACT NUMBER : A239
Clinical profile and surgical outcomes of strabismus associated with thyroid eye disease in an Indian population
ABSTRACT NUMBER : A240
Muscle transplantation for large angle horizontal sensory strabismus
ABSTRACT NUMBER : A241
Comparison of bilateral lateral rectus recession vs unilateral recess and resect for intermittent exotropia in Jakarta, Indonesia
ABSTRACT NUMBER : A242
Periosteal muscle fixation for large angle incomitant exotropia
ABSTRACT NUMBER : A243
Quality of life in patients with Graves’ disease 1 year after the strabismus surgery
Advanced Search

MOST VIEWED ABSTRACTS


  • This Week
  • This Month
  • All Time

    PERSISTENCE TO AFLIBERCEPT THERAPY IN WET AMD PATIENTS ENGAGED WITH THE SMARTSIGHT SUPPORT PROGRAM

    Through the Cloudy Lens – Outreach in the Top End

    EFFICACY OF INTRAVITREAL AFLIBERCEPT ADMINISTERED USING TREAT- AND-EXTEND REGIMEN OVER 2 YEARS IN PATIENTS WITH NEOVASCULAR AGE- RELATED MACULAR DEGENERATION: BASELINE CHARACTERISTICS OF ARIES

    PERSISTENCE TO AFLIBERCEPT THERAPY IN WET AMD PATIENTS ENGAGED WITH THE SMARTSIGHT SUPPORT PROGRAM

    Nascent Geographic Atrophy (nGA) – an early outcome marker for progression of intermediate Age-related Macular Degeneration (AMD)

    THE CLINICAL USE OF TOPICAL HYPERTONIC SALINE EYE DROPS IN A TERTIARY REFERRAL EYE CARE CENTRE IN SYDNEY, AUSTRALIA

    PERSISTENCE TO AFLIBERCEPT THERAPY IN WET AMD PATIENTS ENGAGED WITH THE SMARTSIGHT SUPPORT PROGRAM

    Nascent Geographic Atrophy (nGA) – an early outcome marker for progression of intermediate Age-related Macular Degeneration (AMD)

    VERTICAL PRISM FUSION RANGES IN A NORMAL POPULATION

RECENT MEETINGS


2019 RANZCO, 51st Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists
08 November – 12 November 2019
Sydney, Australia
2018 RANZCO, 50th Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists
17 November - 21 November 2018
Adelaide Convention Centre, South Australia

ARCHIVES

© COPYRIGHT 2016 The Royal Australian and New Zealand College of Ophthalmologists